Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 USD | +241.30% | +241.30% | +241.30% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health Cares and Supplements Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -95.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -95.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 46 | 19-08-19 |
Li Yang
BRD | Director/Board Member | 55 | 19-08-19 |
Hua Xie
BRD | Director/Board Member | 54 | 19-08-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 46 | 19-08-19 |
Hua Xie
BRD | Director/Board Member | 54 | 19-08-19 |
Li Yang
BRD | Director/Board Member | 55 | 19-08-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,000,000 | 36,000,000 ( 36.36 %) | 0 | 36.36 % |
Company contact information
Goldenwell Biotech, Inc.
581 Boston Mills Road Suite 300
44236, Hudson
+
Sector
1st Jan change | Capi. | |
---|---|---|
+241.30% | 19.8M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- GWLL Stock
- Company Goldenwell Biotech, Inc.